Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 574 clinical trials
Featured trial
The Efficacy and Safety of Rilzabrutinib in Patients Aged 10 to 65 Years With Sickle-cell Disease (LIBRA)

  • Treatment duration: 52-week double-blind period (Part A); LTE period (Part B) from the (FPI until the last participant who enters the LTE has completed 52 weeks
  • Visit frequency: Week visits based on the Schedule of Assessments
    • ul>

    Online studies
    • 0 views
    • 18 May, 2025
    • Online study
    Featured trial
    l Investigation of Robotic-assisted TKA (RA-TKA) With Skywalker and Evolution Medial Pivot Knee (eMP Knee) (123)

    This is a prospective trial that attempts to develop evidence on the safety and performance of RA-TKA (Robotic-assisted total knee arthroplasty) with Skywalker and eMP (Evolution Medial Pivot) knee. Moreover to evaluate performance of eMP patients with Skywalker (in comparison to eMP with conventional instrumentations and non-MP TKAs)

    Online studies
    Accepts healthy volunteers
    • 0 views
    • 19 May, 2025
    • Online study
    Featured trial
    TriPRIL CAR T Cells in Multiple Myeloma

    This research study involves the study of TriPRIL CAR T Cells for treating people with relapsed or refractory multiple myeloma and to understand the side effects when treated with TriPRIL CAR T Cells.

    This research study involves the study drugs:.

    <ul>
  • TriPRIL CAR T Cells
  • Fludarabine and Cyclophosphamide: Standardly used chemotherapy drugs as part …

    • 0 views
    • 24 Nov, 2025
    • 1 location
    Featured trial
    Switch Maintenance in Pancreatic

    The names of the study drugs involved in this study are:

    <ul>
  • Domvanalimab (also known as AB154)
  • Zimberelimab (also known as AB122)
  • APX005M
    • ul>

    • 0 views
    • 24 Nov, 2025
    • 1 location
    Featured trial
    A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma  

    The names of the study drugs and vaccine involved in this study are:

    <ul>
  • DC/MM fusion vaccine (a personalized cancer vaccine in which harvested participant tumor cells are fused with harvested participant dendritic blood cells)
  • Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) (a type of growth factor)
  • Elranatamab (a type of T-cell engager antibody)
    • ul>

    • 0 views
    • 13 Mar, 2026
    • 2 locations
    Featured trial
    Auricular Acupressure for Premenstrual Syndrome in Female Students

  • Be monitored for any adverse effects during the 8-week trial period.
    • ul>

    • 0 views
    • 30 Nov, 2025
    • 4 locations
    Featured trial
    Test RTE

    Study Overview Study Details Eligibility Trial Primary Objective:
    To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD)
    Secondary Objectives:
    To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation
    To continue to …

    • 0 views
    • 19 Feb, 2024
    • 1 location
    Featured trial
    Study on the Visual Condition in Parkinson's Disease  

    Non motor symptoms and signs in Parkinson's disease (PD) also include a series of visual deficits; deepening these aspects could be useful for a better management of symptoms, to standardize a specific protocol for the issues related to vision and also to understand how these aspects are important for the …

    motor symptoms
    parkinson's disease
    • 0 views
    • 19 Feb, 2024
    • 2 locations
    Featured trial
    Venous Thromboembolism in Primary Pancreatic Tumour Resection (PaTR-VTE)

    This study will evaluate the development of venous thromboembolism (VTE) and possible determinants in patients with primary pancreatic cancer undergoing pancreatic cancer resection.

    • 0 views
    • 24 Nov, 2025
    Featured trial
    Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma

    This project will evaluate the efficacy and safety of the conditioning regimen bortezomib-bendamustine-melphalan (BBM) in combination with autologous hematopoietic stem cell transplantation (ASCT) in relapsed multiple myeloma given from 2011 to 2018 at Uppsala University Hospital. This approach will be retrospectively compared to high dose melphalan (HDM) in the same …

    • 0 views
    • 01 Dec, 2025
    • 2 locations